AquaVanta Harvests — Financial Projections
The financial projections presented below are based on conservative assumptions reviewed by independent industry consultants. All figures are in South African Rand (ZAR) unless otherwise stated. Key assumptions underlying these projections are detailed in Section 11.5.
Section 11 · Business Plan
Financial Projections
The financial projections presented below are based on conservative assumptions reviewed by independent industry consultants. All figures are in South African Rand (ZAR) unless otherwise stated. Key assumptions underlying these projections are detailed in Section 11.5.
At an EBITDA margin exceeding 35%, with a ZAR 11.3 million Year-5 net profit, a 48% Year-5 ROIC and an NPV of ZAR 28.5 million at a 15% WACC.
The financial projections presented below are based on conservative assumptions reviewed by independent industry consultants. All figures are in South African Rand (ZAR) unless otherwise stated. Key assumptions underlying these projections are detailed in Section 11.5.
11.1 Revenue Forecast
11.2 Projected Income Statement (Profit & Loss)
Five-Year Projected Income Statement (ZAR ‘000):
| Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Revenue | 8,400 | 14,200 | 24,000 | 32,500 | 42,000 |
| Cost of Goods Sold | (5,460) | (8,804) | (13,440) | (17,225) | (21,000) |
| Gross Profit | 2,940 | 5,396 | 10,560 | 15,275 | 21,000 |
| Gross Margin % | 35.0% | 38.0% | 44.0% | 47.0% | 50.0% |
| Operating Expenses: | |||||
| Staff Costs | (680) | (920) | (1,560) | (1,950) | (2,310) |
| Feed & Nutrition | (4,368) | (7,100) | (12,480) | (16,250) | (21,000) |
| Electricity & Water | (336) | (498) | (720) | (910) | (1,050) |
| Maintenance & Repairs | (168) | (284) | (480) | (650) | (840) |
| Marketing & Distribution | (252) | (426) | (720) | (975) | (1,260) |
| Admin & Overheads | (210) | (355) | (480) | (585) | (630) |
| Depreciation | (540) | (640) | (960) | (1,100) | (1,200) |
| Total Operating Expenses | (6,554) | (10,223) | (17,400) | (22,420) | (28,290) |
| EBITDA | 1,512 | 3,124 | 6,720 | 10,400 | 14,700 |
| EBITDA Margin % | 18.0% | 22.0% | 28.0% | 32.0% | 35.0% |
| Operating Profit (EBIT) | 972 | 2,484 | 5,760 | 9,300 | 13,500 |
| Interest Expense | (360) | (320) | (280) | (220) | (160) |
| Profit Before Tax | 612 | 2,164 | 5,480 | 9,080 | 13,340 |
| Taxation (27%) | (165) | (584) | (1,480) | (2,452) | (3,602) |
| Net Profit After Tax | 447 | 1,580 | 4,000 | 6,628 | 9,738 |
| Net Profit Margin % | 5.3% | 11.1% | 16.7% | 20.4% | 23.2% |
11.3 Projected Balance Sheet
Five-Year Projected Balance Sheet (ZAR ‘000):
| Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| ASSETS | |||||
| Non-Current Assets | |||||
| Property, Plant & Equipment | 14,400 | 14,760 | 19,260 | 20,160 | 20,960 |
| Less: Accumulated Depreciation | (540) | (1,180) | (2,140) | (3,240) | (4,440) |
| Net Fixed Assets | 13,860 | 13,580 | 17,120 | 16,920 | 16,520 |
| Biological Assets (Fish Stock) | 1,200 | 1,800 | 3,000 | 3,500 | 4,200 |
| Total Non-Current Assets | 15,060 | 15,380 | 20,120 | 20,420 | 20,720 |
| Current Assets | |||||
| Inventory (Feed & Supplies) | 420 | 710 | 1,200 | 1,625 | 2,100 |
| Trade Receivables | 700 | 1,183 | 2,000 | 2,708 | 3,500 |
| Cash & Equivalents | 1,320 | 2,580 | 4,200 | 8,400 | 15,100 |
| Total Current Assets | 2,440 | 4,473 | 7,400 | 12,733 | 20,700 |
| TOTAL ASSETS | 17,500 | 19,853 | 27,520 | 33,153 | 41,420 |
| EQUITY & LIABILITIES | |||||
| Shareholders' Equity | |||||
| Share Capital | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained Earnings | (1,553) | 27 | 4,027 | 10,655 | 20,393 |
| Total Equity | 16,447 | 18,027 | 22,027 | 28,655 | 38,393 |
| Non-Current Liabilities | |||||
| Long-Term Borrowings | 0 | 0 | 3,500 | 2,800 | 1,400 |
| Current Liabilities | |||||
| Trade Payables | 700 | 1,183 | 1,400 | 1,200 | 1,050 |
| Short-Term Borrowings | 353 | 643 | 593 | 498 | 577 |
| Total Current Liabilities | 1,053 | 1,826 | 1,993 | 1,698 | 1,627 |
| TOTAL EQUITY & LIABILITIES | 17,500 | 19,853 | 27,520 | 33,153 | 41,420 |
11.4 Projected Cash Flow Statement
Five-Year Projected Cash Flow Statement (ZAR ‘000):
| Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| OPERATING ACTIVITIES | |||||
| Net Profit After Tax | 447 | 1,580 | 4,000 | 6,628 | 9,738 |
| Add: Depreciation | 540 | 640 | 960 | 1,100 | 1,200 |
| Changes in Working Capital: | |||||
| (Increase)/Decrease in Receivables | (700) | (483) | (817) | (708) | (792) |
| (Increase)/Decrease in Inventory | (420) | (290) | (490) | (425) | (475) |
| Increase/(Decrease) in Payables | 700 | 483 | 217 | (200) | (150) |
| Change in Biological Assets | (1,200) | (600) | (1,200) | (500) | (700) |
| Net Cash from Operations | (633) | 1,330 | 2,670 | 5,895 | 8,821 |
| INVESTING ACTIVITIES | |||||
| Capital Expenditure (PPE) | (14,400) | (360) | (4,500) | (900) | (800) |
| Processing Facility | 0 | 0 | (1,000) | 0 | 0 |
| Net Cash Used in Investing | (14,400) | (360) | (5,500) | (900) | (800) |
| FINANCING ACTIVITIES | |||||
| Equity Capital Raised | 18,000 | 0 | 0 | 0 | 0 |
| Long-Term Borrowings Raised | 0 | 0 | 3,500 | 0 | 0 |
| Loan Repayments | 0 | 0 | 0 | (700) | (1,400) |
| Short-Term Facility Movement | 353 | 290 | (50) | (95) | 79 |
| Net Cash from Financing | 18,353 | 290 | 3,450 | (795) | (1,321) |
| Net Increase/(Decrease) in Cash | 3,320 | 1,260 | 620 | 4,200 | 6,700 |
| Opening Cash Balance | 0 | 1,320 | 2,580 | 4,200 | 8,400 |
| Closing Cash Balance | 1,320 | 2,580 | 4,200 | 8,400 | 15,100 |
11.5 Key Financial Assumptions
| Assumption | Value / Basis |
| Average Selling Price (Blended) | R70/kg (Year 1) escalating to R93/kg (Year 5) |
| Production Volume | 120 tonnes (Year 1) to 450 tonnes (Year 5) |
| Feed Conversion Ratio (FCR) | 1.4 (blended RAS/pond) |
| Feed Cost | R12–R15/kg (escalating at 8% p.a.) |
| Survival Rate | 87% (RAS), 82% (ponds) |
| Revenue Growth Rate | Phase-driven: 69% (Y2), 69% (Y3), 35% (Y4), 29% (Y5) |
| Inflation (CPI) | 5.0% per annum |
| Electricity Cost Escalation | 12% per annum |
| Staff Cost Escalation | CPI + 2% per annum |
| Corporate Tax Rate | 27% |
| Discount Rate (WACC) | 15% |
| Debt Facility Interest Rate | 12% (prime + 1.5%) |
| Capital Expenditure (Phase 2) | R5.5M funded from operating cash flow + R3.5M term loan |
| Depreciation Method | Straight-line over 10–20 years (buildings) and 5–10 years (equipment) |
| Working Capital Days | Receivables: 30 days; Payables: 30 days; Inventory: 18 days |
11.6 Break-Even Analysis
AquaVanta is projected to achieve operational break-even by approximately Month 18 of operations (within Year 2). This timeline reflects the 6–8 month biological grow-out period before first harvest revenue, followed by a ramp-up phase as production volumes increase and market penetration improves.
11.7 Investment Return Metrics
The venture delivers compelling risk-adjusted returns across all standard investment evaluation metrics:
| Metric | Value | Commentary |
| Internal Rate of Return (IRR) | 34% | Exceeds 25% hurdle rate for agricultural PE |
| Net Present Value (NPV @ 15%) | R 28.5 million | Strong positive NPV indicates value creation |
| Payback Period | 3.2 years | Within standard 3–5 year PE horizon |
| Return on Invested Capital (Year 5) | 48% | Demonstrates efficient capital deployment |
| Equity Multiple (5-Year) | 2.7x | Attractive for growth-stage agriculture investment |
This document contains proprietary and confidential information. Distribution without written consent is prohibited.